Atlas Venture Opportunity Fund II, L.P.

Other

US·SEC (Form 4)

Day One Biopharmaceuticals, Inc.

0

Total declarations

0

Company

€11m

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Explore the complete record of transactions filed by Atlas Venture Opportunity Fund II, L.P.. Officer active across 1 companies, notably Day One Biopharmaceuticals, Inc.. Cumulatively, 1 reports have been published. Total volume traded: €10.9m. The latest transaction was filed on 17 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.

Declarations1 total

Executives▲PurchaseDDay One Biopharmaceuticals, Inc.42SEC

A

Atlas Venture Opportunity Fund II, L.P.

€11m766,667 shares@ €14.22221.14% mcap100.0% of flow

Common Stock

SEC:0001209191-22-038713:0·17 Jun 2022

Ideal exit: 14 Mar 2023 (T+270)

SEC ↗

1 of 1 declaration